EP 1476154 A2 20041117 - USE OF INHIBITORS OF THE SODIUM-DEPENDENT CHLORIDE-BICARBONATE-EXCHANGER FOR TREATING THROMBOTIC AND INFLAMMATORY DISEASES
Title (en)
USE OF INHIBITORS OF THE SODIUM-DEPENDENT CHLORIDE-BICARBONATE-EXCHANGER FOR TREATING THROMBOTIC AND INFLAMMATORY DISEASES
Title (de)
VERWENDUNG VON INHIBITOREN DES NATRIUM-ABHÄNGIGEN CHLORID-BICARBONAT-AUSTAUSCHERS ZUR BEHANDLUNG VON THROMBOTISCHEN UND INFLAMMATORISCHER ERKRANKUNGEN
Title (fr)
UTILISATION D'INHIBITEURS DE L'ECHANGEUR CHLORURE-BICARBONATE SODIUM-DEPENDANT POUR TRAITER DES AFFECTIONS THROMBOTIQUES ET INFLAMMATOIRES
Publication
Application
Priority
- DE 10206354 A 20020214
- EP 0301100 W 20030205
Abstract (en)
[origin: WO03068224A2] The invention relates to the use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thromobotic and inflammatory diseases. Said inhibitors of the cellular sodium-dependent chloride-bicarbonate-exchanger exhibit an inhibiting effect on the secretion of the Von Willebrand-factor. Said inhibitors can be used in the treatment of thrombotic and inflammatory diseases.
IPC 1-7
A61K 31/4174; A61K 31/381; A61K 31/166; A61K 31/402; A61K 31/496; A61K 31/538; A61K 31/47; A61K 31/435; A61K 31/4439
IPC 8 full level
C07D 233/70 (2006.01); A61K 31/166 (2006.01); A61K 31/381 (2006.01); A61K 31/402 (2006.01); A61K 31/404 (2006.01); A61K 31/407 (2006.01); A61K 31/4174 (2006.01); A61K 31/435 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/538 (2006.01); A61K 31/616 (2006.01); A61K 31/727 (2006.01); A61K 38/48 (2006.01); A61K 38/55 (2006.01); A61K 45/00 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 333/34 (2006.01)
CPC (source: EP)
A61K 31/166 (2013.01); A61K 31/381 (2013.01); A61K 31/402 (2013.01); A61K 31/4174 (2013.01); A61K 31/435 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/538 (2013.01); A61P 7/02 (2017.12); A61P 9/00 (2017.12); A61P 9/08 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 19/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 03068224A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03068224 A2 20030821; WO 03068224 A3 20031224; AR 038837 A1 20050126; AU 2003208792 A1 20030904; BR 0307637 A 20050104; CA 2476454 A1 20030821; DE 10206354 A1 20030828; EP 1476154 A2 20041117; JP 2005525338 A 20050825; MX PA04007007 A 20041011; TW 200306808 A 20031201
DOCDB simple family (application)
EP 0301100 W 20030205; AR P030100449 A 20030212; AU 2003208792 A 20030205; BR 0307637 A 20030205; CA 2476454 A 20030205; DE 10206354 A 20020214; EP 03706428 A 20030205; JP 2003567406 A 20030205; MX PA04007007 A 20030205; TW 92102812 A 20030212